Company Details

  • Zhiyuan Biotchnology

  •  [Shandong,China]
  • Business Type:Manufacturer
  • Main Mark: Africa , Americas , Asia , Caribbean , Europe , North Europe , Oceania , West Europe , Worldwide , East Europe , Middle East
  • Exporter:51% - 60%
  • Certs:ISO9001, ISO14001, FDA
Inquiry Basket ( 0 )

Zhiyuan Biotchnology

Home > News > New Drug In The Central System - Hydroxypropyl Beta-cyclodextrin
News

New Drug In The Central System - Hydroxypropyl Beta-cyclodextrin

Hydroxypropyl beta-cyclodextrin (HP-β-CD) can be used as a carrier for central system drugs.

When intraocular administration of opiates to rats, HP-β-CD prolongs anesthesia time and reduces the occurrence of side effects on the spikes. The reason is that HP-β-CD is similar to a slow-release container, reducing free drug distributed from the cerebrospinal fluid into the blood. On the other hand, when HP-β-CD is injected into the brain of rats, it can quickly enter the circulatory system and finally be discharged through the urine.

New drug in the central system - hydroxypropyl beta-cyclodextrin

Share to:  
Communicate with Supplier?Supplier
Klaus chen Mr. Klaus chen
What can I do for you?
Chat Now Contact Supplier